Quality Control of CE-Certified Phonak Hearing Aids - 2018_42
1 other identifier
interventional
20
1 country
1
Brief Summary
Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2019
CompletedFirst Submitted
Initial submission to the registry
May 3, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedMay 6, 2019
May 1, 2019
29 days
May 3, 2019
May 3, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Subjective perception of the T-Coil Sound Quality
The primary objective of this study is to measure that the overall sound Quality of the T-Coil program \[subjective satisfaction rating on a scale from 0%-100% in 1% steps\] of the investigational device is rated as at least as 60% or better \[60% is the border between 'ok' and 'satisfied'\] after a test period with daily life situations.
4 weeks
Secondary Outcomes (1)
Program switch-back workflow into T-Coil program
4 weeks
Other Outcomes (3)
Observation of the system stability
4 weeks
Sound Quality rating of T-Coil program under lab conditions
4 weeks
Subjective perception of audio artefacts in T-Coil program
4 weeks
Study Arms (1)
Phonak Audéo M90-T
EXPERIMENTALThe Phonak Audéo M90-T is a Receiver-in-the-canal Hearing aid with direct connectivity functionality and a T-Coil from Phonak which will be fitted to the participants individual Hearing loss.
Interventions
Receiver in the canal (RIC) Hearing aid form Phonak which will be fitted to the participants individual Hearing loss.
Eligibility Criteria
You may qualify if:
- Adult hearing impaired persons (minimum age: 18 years, moderate to severe Hearing loss)
- Good written and spoken (Swiss) German language skills
- Healthy outer ear
- Ability to fill in a questionnaire (p/eCRF) conscientiously
- Willingness to wear Receiver in the canal hearing aids
- Informed Consent as documented by signature
- Owning a compatible smartphone
You may not qualify if:
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments in Stäfa (Switzerland)
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Known psychological problems
- Central hearing disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sonova AGlead
Study Sites (1)
Sonova AG
Stäfa, Canton of Zurich, 8712, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2019
First Posted
May 6, 2019
Study Start
January 9, 2019
Primary Completion
February 7, 2019
Study Completion
February 28, 2019
Last Updated
May 6, 2019
Record last verified: 2019-05